<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02855333</url>
  </required_header>
  <id_info>
    <org_study_id>KLiestal</org_study_id>
    <nct_id>NCT02855333</nct_id>
  </id_info>
  <brief_title>Feasibility, Safety and QoL After Merendino Procedure</brief_title>
  <acronym>MER</acronym>
  <official_title>The Merendino Procedure for Benign or Early Malignant Lesions of the Distal Esophagus/Gastroesophageal Junction is Feasible, Safe and Provides Good QoL</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Liestal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Liestal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyse retrospectively the early postoperative and
      functional outcome of patients (pts) after Merendino procedure for benign or early malignant
      lesions of the distal part of the esophagus or the gastroesophageal junction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Between 2004 and 2013, 14 pts had transhiatal resection of median 8 (6-10) cm of distal
      esophagus including the gastroesophageal junction. Locoregional lymphadenectomy was performed
      in all patients with (suspected) early adenocarcinoma. In case of vagus nerve resection,
      pyloromyectomy and cholecystectomy were done. A pediculated isoperistaltic jejunal segment of
      15-18 cm length was interponed between esophageal stump and remaining stomach by end-to-side
      anastomoses. At least one postoperative contrast examination of the anastomoses was done in
      all pts. Quality of life was assessed by using the EORTC QLQ-OES18 survey, recording
      patients' general activity and condition and specific gastrointestinal symptoms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Life (QoL)</measure>
    <time_frame>up to 10 years after surgery</time_frame>
    <description>EORTC QLQ-C30 and QLQ-OES24 questionnaire (global health status item, functional and symptom scale items)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative complications</measure>
    <time_frame>up to 1 day after surgery</time_frame>
    <description>Blood loss (ml), requirement for blood transfusion (units), operation time (min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>up to 100 days after surgery</time_frame>
    <description>Morbidity (re-intervention rate, re-operation rate), in-hospital mortality</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">26</enrollment>
  <condition>Benign or Early Malignant Lesion of the Distal Esophagus or Gastro-esophageal Junction Requiring Surgical Resection</condition>
  <arm_group>
    <arm_group_label>Merendino Group (MER)</arm_group_label>
    <description>Patients who underwent merendino procedure for benign or early malignant lesions of the distal esophagus/gastroesophageal junction Perioperative data and EORTC and QLQ-C30 / QLQ-OES24 questionnaire</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group (CON)</arm_group_label>
    <description>Patients who underwent alternative surgery for benign or early malignant lesions of the distal esophagus/gastroesophageal junction Perioperative data and EORTC and QLQ-C30 / QLQ-OES24 questionnaire</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>EORTC and QLQ-C30 / QLQ-OES24 questionnaire</intervention_name>
    <description>EORTC and QLQ-C30 / QLQ-OES24 questionnaire was sent to patients to asses QoL after MER or CON procedure</description>
    <arm_group_label>Merendino Group (MER)</arm_group_label>
    <arm_group_label>Control Group (CON)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who underwent Merendino procedure between 08/2004 and 02/2013 at the Kantonal
        Hospital of Baselland, Liestal (Switzerland) were included into the Merendino (MER) group.
        Considering indication for surgery, age, ASA score, and co-morbidities, patients who
        underwent gastrectomy during the same period were matched for control (CON) group.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  alive

          -  MER or CON procedure

          -  informed consent

          -  CON patients were matched according to diagnosis, Age and ASA score

        Exclusion Criteria:

          -  withdrawal of informed consent

          -  legal incapacity

          -  limitations in mental state or medical condition precluding questioning (only QoL
             data)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph A Maurer, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hirslanden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kantonsspital Baselland, Liestal</name>
      <address>
        <city>Liestal</city>
        <state>Basel-Land</state>
        <zip>4410</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Zapletal C, Lorenz D. Quality of life after surgical treatment of early Barrett's cancer: a prospective comparison of the Ivor-Lewis resection versus the modified Merendino resection. A statistical hint: reply. World J Surg. 2014 Nov;38(11):3034. doi: 10.1007/s00268-014-2723-8.</citation>
    <PMID>25189438</PMID>
  </reference>
  <reference>
    <citation>Götzky K, Jähne J. [Quality of life after operation for early Barrett's cancer: a prospective comparison of Ivor Lewis resection versus modified Merendino resection]. Chirurg. 2014 Sep;85(9):822. doi: 10.1007/s00104-014-2856-1. German.</citation>
    <PMID>25123190</PMID>
  </reference>
  <reference>
    <citation>Mangano A, Lianos GD, Rausei S, Boni L, Dionigi G. Quality of life after surgical treatment of early Barrett's cancer: a prospective comparison of the Ivor-Lewis resection versus the modified Merendino resection. A statistical hint. World J Surg. 2014 Nov;38(11):3033. doi: 10.1007/s00268-014-2624-x.</citation>
    <PMID>24791672</PMID>
  </reference>
  <reference>
    <citation>Zapletal Ch, Heesen Ch, Origer J, Pauthner M, Pech O, Ell Ch, Lorenz D. Quality of life after surgical treatment of early Barrett's cancer: a prospective comparison of the Ivor-Lewis resection versus the modified Merendino resection. World J Surg. 2014 Jun;38(6):1444-52. doi: 10.1007/s00268-013-2410-1.</citation>
    <PMID>24378548</PMID>
  </reference>
  <reference>
    <citation>Hölscher AH, Vallböhmer D, Gutschow C, Bollschweiler E. Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure? Langenbecks Arch Surg. 2009 May;394(3):417-24. doi: 10.1007/s00423-008-0429-9. Epub 2008 Nov 7. Review.</citation>
    <PMID>18989696</PMID>
  </reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 13, 2016</study_first_submitted>
  <study_first_submitted_qc>August 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2016</study_first_posted>
  <last_update_submitted>August 3, 2016</last_update_submitted>
  <last_update_submitted_qc>August 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Merendino procedure</keyword>
  <keyword>Feasibility, Safety and QoL of the Merendino procedure</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

